ZURICH: Roche plans to steer clear of the wave of big takeovers sweeping through the healthcare industry and focus instead on small acquisitions and partnerships, the Swiss drugmaker’s chief executive said in an interview published on Saturday.

“We’re sticking to our previous strategy. This includes targeted, small acquisitions and partnerships like the ones we have carried out in recent months,” Severin Schwan told business newspaper Finanz und Wirtschaft.